Atai life sciences to participate in october investor events & host virtual r&d day

New york and berlin, oct. 04, 2022 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in in the following investor events & host a virtual r&d day in october:
ATAI Ratings Summary
ATAI Quant Ranking